Net Deals Web Search

Search results

  1. Results From The WOW.Com Content Network
  2. Novartis Completes Purchase of Alcon Majority Stake ... - AOL

    www.aol.com/news/2010-08-26-novartis-alcon-buy...

    The total cost to Novartis for the 77% stake in Alcon was $38.7 billion ($168 per share). In the deal's first phase, Novartis acquired a 25% stake in Alcon from Nestlé for $10.4 billion in July 2008.

  3. Alcon - Wikipedia

    en.wikipedia.org/wiki/Alcon

    Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. [ 3 ] [ 4 ] Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals , focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies.

  4. Novartis - Wikipedia

    en.wikipedia.org/wiki/Novartis

    Alcon: At the time Novartis bought Alcon, they had annual sales of $6.5 billion and a net income of $2 billion. [127] In April 2019, Novartis completed the spin-off of Alcon as a separate commercial entity. [73] Sandoz: As of 2013, Sandoz has been recognized as the world's second-largest generic drug company.

  5. Novartis Completes Purchase of Alcon Majority Stake ... - AOL

    www.aol.com/2010/08/26/novartis-alcon-buy...

    More than two years after beginning the acquisition process, Swiss pharmaceutical company Novartis (NVS) said Thursday that it has finally completed the purchase of a 77% majority stake in U.S ...

  6. Novartis (NVS) has worked aggressively to purchase Alcon (ACL), a major eye-care company, from Nestlé. The deal-making started a couple of years ago when Novartis shelled out $10.4 billion to ...

  7. List of largest pharmaceutical mergers and acquisitions

    en.wikipedia.org/wiki/List_of_largest...

    1. 2015. Pfizer. Allergan, plc. 160. 206. In November 2015 Pfizer announced it would acquire Allergan, plc for $160 billion ($206 billion, adjusted for inflation). However, this deal was cancelled in April 2016 due to new US tax inversion rules. [12] [13] Had this transaction been completed, this would have been the largest within this industry.

  8. Novartis to Spin-Off Alcon as Separate Trading Company - AOL

    www.aol.com/news/novartis-spin-off-alcon...

    For premium support please call: 800-290-4726 more ways to reach us

  9. Nepafenac - Wikipedia

    en.wikipedia.org/wiki/Nepafenac

    At the time of the purchase, a proposal for a merger under Swiss merger law was given to the Alcon board of directors. [22] The merger was agreed upon on December 15, 2010, making Alcon "the second largest division within Novartis." [22] The merger was completed on April 8, 2011. [23] Ilevro was launched by Alcon on January 21, 2013. [24]